135 related articles for article (PubMed ID: 28120338)
1. The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
Busby J; Murchie P; Murray L; Iversen L; Lee AJ; Spence A; Watson MC; Cardwell CR
Int J Cancer; 2017 Apr; 140(8):1828-1835. PubMed ID: 28120338
[TBL] [Abstract][Full Text] [Related]
2. The role of 5α-reductase inhibitors in gastro-oesophageal cancer risk: A nested case-control study.
Busby J; Karasneh R; Murchie P; McMenamin Ú; Gadalla SM; Camargo MC; Iversen L; Lee AJ; Spence AD; Cardwell CR
Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):48-56. PubMed ID: 31713940
[TBL] [Abstract][Full Text] [Related]
3. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.
Green J; Czanner G; Reeves G; Watson J; Wise L; Beral V
BMJ; 2010 Sep; 341():c4444. PubMed ID: 20813820
[TBL] [Abstract][Full Text] [Related]
4. Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2013 Jan; 346():f114. PubMed ID: 23325866
[TBL] [Abstract][Full Text] [Related]
5. Exposure to weak opioids and risk of gastrointestinal tract cancers: A series of nested case-control studies.
Houston MG; McMenamin Ú; Johnston B; McDowell RD; Hughes CM; Murchie P; Cardwell CR
Br J Clin Pharmacol; 2023 Sep; 89(9):2757-2766. PubMed ID: 37117154
[TBL] [Abstract][Full Text] [Related]
6. Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.
Spence AD; Busby J; Murchie P; Kunzmann AT; McMenamin ÚC; Coleman HG; Johnston BT; O'Rorke MA; Murray LJ; Iversen L; Lee AJ; Cardwell CR
Int J Cancer; 2018 Jul; 143(1):22-31. PubMed ID: 29396851
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
Wright E; Schofield PT; Seed P; Molokhia M
PLoS One; 2012; 7(10):e47616. PubMed ID: 23112825
[TBL] [Abstract][Full Text] [Related]
8. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
García Rodríguez LA; Lagergren J; Lindblad M
Gut; 2006 Nov; 55(11):1538-44. PubMed ID: 16785284
[TBL] [Abstract][Full Text] [Related]
9. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea.
Jung SY; Sohn HS; Park EJ; Suh HS; Park JW; Kwon JW
PLoS One; 2016; 11(3):e0150531. PubMed ID: 26937968
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.
Spence AD; Busby J; Johnston BT; Baron JA; Hughes CM; Coleman HG; Cardwell CR
Gastroenterology; 2018 Mar; 154(4):849-860.e1. PubMed ID: 29122547
[TBL] [Abstract][Full Text] [Related]
11. Exposure to oral bisphosphonates and risk of esophageal cancer.
Cardwell CR; Abnet CC; Cantwell MM; Murray LJ
JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457
[TBL] [Abstract][Full Text] [Related]
12. Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
García Rodríguez LA; Soriano-Gabarró M; Vora P; Cea Soriano L
Int J Cancer; 2020 Nov; 147(9):2394-2404. PubMed ID: 32329063
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
Busby J; McMenamin Ú; Spence A; Johnston BT; Hughes C; Cardwell CR
Aliment Pharmacol Ther; 2018 Jan; 47(2):279-288. PubMed ID: 29105106
[TBL] [Abstract][Full Text] [Related]
14. Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study.
Cardwell CR; McDowell RD; Hughes CM; Busby J; Murchie P
Cancer Epidemiol; 2024 Jun; 90():102552. PubMed ID: 38447250
[TBL] [Abstract][Full Text] [Related]
15. Trends in oesophago-gastric surgery in Scotland.
Oniscu GC; Paterson-Brown S
Surgeon; 2003 Feb; 1(1):51-7. PubMed ID: 15568427
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer.
Crumley AB; McMillan DC; McKernan M; McDonald AC; Stuart RC
Br J Cancer; 2006 Mar; 94(5):637-41. PubMed ID: 16479253
[TBL] [Abstract][Full Text] [Related]
17. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
Ljung R; Martin L; Lagergren J
Eur J Cancer; 2011 Sep; 47(14):2128-32. PubMed ID: 21489778
[TBL] [Abstract][Full Text] [Related]
18. Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal).
Collins GS; Altman DG
Eur J Cancer; 2013 Mar; 49(5):1040-8. PubMed ID: 23159533
[TBL] [Abstract][Full Text] [Related]
19. Identifying patients with suspected gastro-oesophageal cancer in primary care: derivation and validation of an algorithm.
Hippisley-Cox J; Coupland C
Br J Gen Pract; 2011 Nov; 61(592):e707-14. PubMed ID: 22054334
[TBL] [Abstract][Full Text] [Related]
20. A nested case-control study of oesophageal and stomach cancers in the Linxian nutrition intervention trial.
Guo W; Blot WJ; Li JY; Taylor PR; Liu BQ; Wang W; Wu YP; Zheng W; Dawsey SM; Li B
Int J Epidemiol; 1994 Jun; 23(3):444-50. PubMed ID: 7960367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
